The incidence of nosocomial enterococcal infections has increased, and enterococci have become one of the most common nosocomial pathogens (Schaberg et al., 1991; Murray, 1998) . Optimal therapy of serious enterococcal infections usually involves a synergistic combination of an agent that interferes with cell wall biosynthesis, such as ampicillin, and an aminoglycoside. Gentamicin has been the preferred aminoglycoside; however, the increasing prevalence of high-level gentamicin resistance (HLGR) (as high as 52?6 % in China) (Wang et al., 1999), which eliminates this synergistic bactericidal effect, has compromised the effectiveness of therapy. The aac (69) (Ferretti et al., 1986) . This gene for a bifunctional enzyme confers resistance to essentially all clinically available aminoglycosides, except streptomycin, and eliminates the synergism between aminoglycosides and cell-wall-active agents. Three novel genes encoding phosphotransferases, including APH (20) Tai et al., 1998; Kao et al., 2000) . The detection of resistance genes is employed to predict bactericidal synergism in enterococci.
INTRODUCTION
The incidence of nosocomial enterococcal infections has increased, and enterococci have become one of the most common nosocomial pathogens (Schaberg et al., 1991; Murray, 1998) . Optimal therapy of serious enterococcal infections usually involves a synergistic combination of an agent that interferes with cell wall biosynthesis, such as ampicillin, and an aminoglycoside. Gentamicin has been the preferred aminoglycoside; however, the increasing prevalence of high-level gentamicin resistance (HLGR) (as high as 52?6 % in China) (Wang et al., 1999) , which eliminates this synergistic bactericidal effect, has compromised the effectiveness of therapy. The aac(69)-Ie-aph(20)-Ia gene is responsible for the HLGR of strains by encoding AAC(69)-Ie-APH(20)-Ia, a gentamicin-modifying enzyme (Ferretti et al., 1986) . This gene for a bifunctional enzyme confers resistance to essentially all clinically available aminoglycosides, except streptomycin, and eliminates the synergism between aminoglycosides and cell-wall-active agents. Three novel genes encoding phosphotransferases, including APH(20)-Ic, APH(20)-Id and APH(20)-Ib, have been detected (Chow et al., 1997; Tai et al., 1998; Kao et al., 2000) . The detection of resistance genes is employed to predict bactericidal synergism in enterococci.
Resistance to streptomycin can be mediated by ribosomal mutation or by the enzymic modification of the drug. Ribosomal resistance is usually associated with streptomycin MICs >32 000 mg ml
21
, while enzyme-mediated resistance produces lower MICs (Eliopoulos et al., 1984) . The aadE gene (also refered to as the 69-ant gene) is the main streptomycin adenylyltransferase gene detected in Enterococcus (Werner et al., 2001; Derbise et al., 1997) . The aadA gene (also referred to as the 30-ant gene) has also been reported in Gram-negative organisms and Staphylococcus aureus, but has not been reported in Enterococcus (Ahmed & Shimamoto, 2004; Clark et al., 1999) .
Insertion sequences (ISs) are an important source of genetic plasticity in prokaryotes. Tn5281 is often associated with the dissemination of the aac(69)-Ie-aph(20)-Ia gene with IS256 upstream and reverse IS256 downstream in HLGR strains (Simjee et al., 1999; Hallgren et al., 2003) . In contrast, ISEcp1 is often reported to be involved in the mobilization of resistance genes, such as CTX-M in Gram-negative bacteria, but has not been reported in Gram-positive bacteria (Poirel et al., 2005; Cao et al., 2002) . The aadA gene located in a class 1 integron has also been reported in Enterococcus faecalis (Clark et al., 1999) .
The genetic environment of a novel aph(20) allele [aph(20)-Ie] conferring HLGR was investigated, and the surrounding sequences that included the streptomycin adenylyltransferase gene (str) and an ISEcp1-like element were described.
METHODS
Bacterial strains, plasmids, and susceptibility testing. The Enterococcus casseliflavus strain used in this study (HZ95) was originally isolated from the ascites of a patient at the intensive care unit (ICU) of a teaching hospital in China. The strain was identified to the species level by the API 20 Strep system and Vitek GPI (bioMérieux) for Gram-positive organisms, and was confirmed to have the vanC2 gene by PCR amplification. Strains and plasmids used in this study are shown in Screening for strains displaying HLGR. HLGR (MIC >500 mg ml 21 ) was confirmed by an agar screening method according to CLSI (2005) . The isolate was dotted at 10 6 c.f.u. on brain heart infusion (BHI) plates containing gentamicin (500 mg ml 21 ), and was incubated at 35 uC for 24 h. Growth of more than one colony was determined to be the best indicator of HLGR.
Detection of aminoglycoside-resistance genes by PCR. The presence of the genes for the aminoglycoside-modifying enzymes (AMEs) responsible for high-level aminoglycoside resistance was confirmed by PCR. The studied genes were aac (69) (69)-Ia. PCR reactions were done on bacterial lysates. PCR assays were performed to amplify these genes as described previously (Donabedian et al., 2003) . Strains that were positive for aac (69) (69)-Ia in our laboratory were employed as positive controls, and Ent. faecalis ATCC 29212 was used as a negative control. We confirmed all positive results by sequencing the PCR product, for which Ent. faecalis ATCC 29212 was again used as a negative control strain.
Purification, cloning and sequencing of PCR products. PCR products were purified by using the 3S Spin PCR Product Purification kit (Shenergy Biocolor). Cloning was done by standard methods, using the purified PCR products, the pGEM-T Easy vector and E. coli DH5a. The PCR products were sequenced by the dideoxynucleotide chain-termination method on an ABI 377 sequencer. Sequence analysis employed BLAST from the National Center for Biotechnology Information (NCBI). DNAssit version 2.2 software was used to compare similarities among other sequences.
Conjugative experiments. Conjugation experiments were carried out using a broth mating technique between the clinical isolate Ent. casseliflavus HZ95 (displays HLGR and is susceptible to rifampicin and fusidic acid) and Ent. faecalis JH2-2 (fusidic acid and rifampicin resistant and gentamicin susceptible) or Ent. faecium BM4105-RF (rifampicin resistant and gentamicin susceptible), as previously described, with a donor/recipient ratio of 1 : 2. The mating time of broth mating was 4 h (Ike et al., 1998) . Portions of the mixed cultures were then transferred to plates of solid media with appropriate selective antibiotics. Colonies were counted after 48 h incubation at 37 uC.
Plasmid isolation, preparation of probe, and Southern blot hybridization. A Qiagen Plasmid Midi kit was used to extract plasmids in HZ95. Plasmids were digested with the restriction enzyme HindIII. After agarose gel electrophoresis, DNA fragments in the gel were transferred to a nylon membrane. The DNA fragment of the aph(20)-Id gene in the strain HZ95 obtained by PCR amplification (Tai et al., 1998) was purified as described above. The purified fragment (642 bp) was labelled with the Prime-H-Gene 33 P probe labelling kit (Promega) for use as a DNA probe. This study 30 min. The cohesive terminal was repaired and adenosine deoxyriboside (A) was added to the terminal. Purified product (3 ml) was linked with 1 ml pGEM-T Easy vector. The linked product was transformed to E. coli DH5a competent bacteria, and then the resultant bacteria were spread on a MacConkey plate containing 50 mg ampicillin ml 21 and 8 mg gentamicin ml
21
. White colonies designating the E. coli pT95 clone were picked the following day. The plasmid was extracted and digested with EcoRI to check for insertions in the vector DNA. The purified transformant plasmid DNA from E. coli pT95 clones with an insert of the target DNA was used as the template for the walking sequencing reaction (Fig. 1) . A similarity search of the sequence was carried out using the BLAST program available at the NCBI BLAST homepage (http://www.ncbi.nlm.nih.gov/blast/). 
RESULTS

Microbiological characterization
Ent. casseliflavus HZ95 was high-level resistant to gentamicin, netilmicin, tobramicin, kanamycin, amikacin and isepamicin (MICs >1024 mg ml 21 ), but was low-level resistant to streptomycin (MIC=128 mg ml
21
; Table 2 ). MICs of ampicillin, vancomycin, teicoplanin and linezolid for Ent. casseliflavus HZ95 were 256, 1, 1 and 2 mg ml 21 , respectively. Among 102 clinical strains, 68 (66?7 %) isolates displaying HLGR were detected. 
Conjugation, cloning and expression of the gentamicin-resistance gene
No transconjugants were selected by conjugation experiments. The plasmids from HZ95 digested by HindIII were ligated to the pGEM-T Easy vector. After transformation of the ligated products, the gentamicin-resistant transformants were selected. An E. coli DH5a derivative resistant to gentamicin was obtained and named E. coli pT95, and contained an 8?7 kb cloned fragment. Aminoglycoside MICs for E. coli pT95 and E. coli pGEM-T Easy are shown in Table 2 . Repeated attempts to electroporate the native 16 kb plasmid into Ent. faecalis JH2-2 failed. Nucleotide sequencing of the cloned fragment
The nucleotide sequence of the cloned fragment revealed the presence of four ORFs, 8724 bp in total (GenBank accession no. AY939911) (Fig. 1) . The nucleotide and deduced amino acid sequences of these ORFs were compared with the sequences in the GenBank database by the BLAST program.
The first ORF (373-2029 bp) was an insertion sequence 91 % identical to IsEcp1, and contained a transposase gene (tnpA) (561-1823 bp) with 30 bp inverted repeats (IRs) at both ends (GenBank accession no. AY455830).
The second ORF (3536-4441 bp) was the novel HLGR aph ( The third ORF (7074-7982 bp) was the gene of a putative plasmid replication initiator protein (RepD) (GenBank accession no. X92946) which is involved in the introduction of a single-strand nick on the leading strand at the origin of replication and in the initiation of rolling-circle plasmid replication ).
The last ORF (7990-8724 bp) was the truncated streptomycin adenylyltransferase gene (str), interrupted by the internal HindIII site, so that only part of the gene was on the~8 kb fragment sequenced. The str gene belongs to the aminoglycoside adenylyltransferase (aad) family. Its amino acid sequence showed 100 % identity with that of the recently detected plasmid-mediated streptomycin adenylyltransferase gene from isolates of Lactococcus lactis (GenBank accession no. X92946) Projan et al., 1988) . Its amino acid sequence was also 80?3 and 13?9 % identical to 69-streptomycin adenylyltransferase (aadE) and 30-streptomycin adenylyltransferase (aadA), respectively, from Enterococcus (GenBank accession nos AY602212 and AF052459) (Derbise et al., 1997; Ahmed & Shimamoto, 2004; Clark et al., 1999) .
Identification of the aph (20) This bifunctional enzyme can cause the resistance of the enterococcus to essentially all clinically available aminoglycosides, except streptomycin, and eliminates the synergism between aminoglycosides and a cell-wall-active agent (Ferretti et al., 1986) . The complete or truncated Tn5281 containing the aac(69)-Ie-aph(20)-Ia gene with IS256 upstream and/or downstream has been detected worldwide among strains displaying HLGR (Simjee et al., 1999; Hallgren et al., 2003) . This is one explanation for the higher frequency of enterococci with HLGR. APH ( (Chow et al., 1997; Tai et al., 1998; Kao et al., 2000) . The aph(20)-Ic gene is associated with gentamicin resistance (MIC 256-584 mg ml 21 ) and loss of synergism (Chow et al., 1997) . The aph(20)-Id and aph(20)-Ib genes result in high-level resistance to aminoglycosides, except streptomycin (MIC ¢2000 mg ml 21 ), but do not eliminate the synergism between amikacin and a cell-wall-active agent (Tai et al., 1998; Kao et al., 2000) .
In this study, the AME APH (20) (20)-Ie gene, and E. coli pGEM-T Easy, it was shown that the MICs for gentamicin, netilmicin, tobramicin and kanamycin of E. coli pT95 were much higher than those of E. coli pGEM-T Easy. It may be concluded that the aph(20)-Ie gene can lead to resistance to gentamicin, netilmicin, tobramicin and kanamycin, but not to amikacin, isepamicin and streptomycin. The only functional difference between these genes is that the isolate from which aph(20)-Id was obtained had a lower level of resistance to netilmicin than Ent. casseliflavus containing the aph(20)-Ie. We detected the aph(20)-Ie gene not only in Ent. casseliflavus but also in Ent. faecium and Ent. gallinarum detected in screens at our hospital over the course of 1 year.
Downstream of the aph(20)-Ie gene, the presence of the str gene may be the explanation of the low-level streptomycin resistance (MIC=128 mg ml 21 ). The str gene has been reported in L. lactis and was first detected in Enterococcus. We detected the str gene not only in Ent. casseliflavus but also in three Ent. faecalis isolates and one Ent. faecium isolate. The Ent. faecium isolate contained both aph(20)-Ie and str genes.
An upstream ISEcp1-like element was detected with a 22 aa substitution in the transposase compared to that of ISEcp1. ISEcp1 is commonly related to the transmission of resistance genes such as CTX-M-type b-lactamase genes, but has not been reported in Gram-positive bacteria (Poirel et al., 2005; Cao et al., 2002) . Accordingly, we presume that ISEcp1 is relevant to the transmission of aph(20)-Ie and str. According to Donabedian et al. (2003) , the aph(20)-Id and aph(20)-Ib genes, which are rarely found in human isolates, are more prevalent in several food-producing animals, and are transmitted from food-producing animals to humans through the food supply, since gentamicin is commonly used in swine, and widely used in chickens and turkeys. It is presumed that these novel aminoglycoside-modifying genes and the IS in Enterococcus were acquired from the environment. The presence of these two linked aminoglycoside-resistance genes that might have been transferred from diverse bacterial species is another example of how bacteria evolve to become more resistant to a broader spectrum of antimicrobial agents.
